Bupivacaine
Drug ingredientActive ShortageCAS 38396-39-3
This drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.
This chemical is listed as active in US commerce, but no company reported it to EPA’s survey for 2019 or 2023. Sites may have made or imported less than the threshold amount, or none.
Why supply is unknownProduction is reported production, not a complete census of factories. Import value and source-country shares describe a shared customs category, not a separate chemical measurement.
Where It Comes From
Customs basis: HS 293339 · basket
These shares come from HS customs code 293339, which covers 397 tracked chemicals in total. They estimate the category's origin mix, not this chemical specifically.
- Taiwan
- Ukraine
- Sweden
- Argentina
- Canada
- Finland
- Malta
- Israel
- Netherlands
- Denmark
- United Arab Emirates
- Mexico
- Brunei
- Slovakia
- Australia
- South Africa
- Poland
- Latvia
- Lithuania
- Estonia
- Slovenia
- Czech Republic
- Croatia
- Hong Kong
10 FDA-registered drug labelers
Why It Matters
Appears in 3 drug and cosmetic product listings (FDA).
- •Zynrelef
- •Exparel
- •Bupivacaine
- Current shortage
Bupivacaine Hydrochloride Injection
Shortage listed since February 20, 2018
Manufacturer reports: 1 unavailable, 1 available
- Current shortage
Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection
Shortage listed since February 20, 2018
Manufacturer reports: 1 unavailable, 1 available
Vendor Pricing
Prices reflect listed pack sizes. Small research packs run far above bulk rates.
16 more vendors
| Vendor | Country Supplier country. Where available, shows shipping origin. When the supplier ships from a different country than where they are registered, both are shown. Most suppliers show registration country only. | $/g | Pack | Purity |
|---|---|---|---|---|
| Angene Chemical | China → Hong Kong | $5.95 | 100 g | 98% |
| A2B Chem LLC | United States | $7.86 | 100 g | 98% |
| AK Scientific Specialized | United States | $9.12 | 25 g | 95% |
| AA BLOCKS | United States | $10.31 | 100 g | 98% |
| AK Scientific, Inc. | United States | $12.24 | 25 g | 98% |
| Cayman Europe | Estonia | $13.52 | 25 g | 98% |
| Biopharma PEG Scientific Inc. | United States | $31.60 | 25 g | 98% |
| AstaTech, Inc | United States | $40.00 | 5 g | 95% |
| MedKoo Biosciences, Inc | United States | $50.00 | 25 g | 98% |
| Interbioscreen | Hong Kong | $129.00 | 10 g | 95% |
| MedChemExpress MCE | Sweden | $225.06 | 500 mg | 99.96% |
| TargetMol Chemicals | China → United States | $660.00 | 50 mg | 99.99% |
| HTS Biochemie Innovationen | Germany | $1790.00 | 100 mg | 95% |
| Key Organics Ltd. | United Kingdom | $2740.00 | 50 mg | 90% |
| Life Chemicals Inc. | Ukraine → Canada | $4200.00 | 50 mg | 90% |
| Angene | China → Hong Kong | $4266.67 | 30 mg | 98% |
Chemical Identity
Data Sources
- PubChem · compound 2474Retrieved 2026-04-07
- EPA TSCA InventoryRetrieved 2026-04-24
- FDA Drug ShortagesRetrieved 2026-10-04
- US Census international tradeReporting year: 2024 · Retrieved 2026-10-04
Brief citations
Bupivacaine (CAS 38396-39-3) https://chemicalindependence.com/chemical/38396-39-3/ PubChem: 2474. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/2474 EPA TSCA Inventory: CAS 38396-39-3. Retrieved 2026-04-24. https://www.epa.gov/tsca-inventory FDA Drug Shortages: CAS 38396-39-3. Retrieved 2026-10-04. https://www.accessdata.fda.gov/scripts/drugshortages/ US Census international trade: HS 293339 for CAS 38396-39-3. Reporting year: 2024. https://usatrade.census.gov/